Pursuant to the Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting held today i.e., Wednesday, 12th March, 2025 at the registered office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, Gujarat, India - 380 055 which commenced at 03:00 P.M. and concluded at 05:00 P.M. inter-alia has: 1. Considered and approved Valuation Report issued by Mr. Manish Santosh Buchasia, Registered Valuer, Ahmedabad, in accordance with Regulation 164 of SEBI (ICDR) Regulation, 2018. 2. Decided to hold Extra-Ordinary General Meeting ('EGM') of the shareholders of the Company on Friday, 4th April, 2025 at 03:00 P.M. through Video Conferences ('VC') / Other Audio-Visual Means ('OAVM').
Dipna Pharmachem Limited Press Release Mar 12 2025
Filed with BSE · · 1 page · English
Release
Dipna Pharmachem Limited on 6ix
Earlier from Dipna Pharmachem
- Dipna Pharmachem Limited Press Release Mar 07 2025
- Dipna Pharmachem Limited Press Release Feb 24 2025
- Dipna Pharmachem Limited Press Release Feb 11 2025
- Dipna Pharmachem Limited Press Release Feb 06 2025
- Dipna Pharmachem Limited Press Release Jan 30 2025
Later from Dipna Pharmachem
- Dipna Pharmachem Limited Press Release Mar 13 2025
- Dipna Pharmachem Limited Press Release Mar 29 2025
- Dipna Pharmachem Limited Press Release Apr 04 2025
- Dipna Pharmachem Limited Press Release Apr 07 2025
- Dipna Pharmachem Limited Press Release Jul 07 2025
Follow Dipna Pharmachem into a list and get an email when it puts out news.
Follow Dipna Pharmachem